Immune checkpoint inhibitors and their role in MM: pembrolizumab and durvalumab
Changing the strategy: early treatment for improved survival in MM
How immunomodulatory drugs have reinforced the value of the immune system in multiple myeloma
Jesús San Miguel
Can daratumumab be used to treat refractory MM?
Can venetoclax be used to treat multiple myeloma (MM)?